|
TMEM209 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.678000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.292210E-02 |
| Normal-vs-Stage2 |
1.545620E-01 |
| Normal-vs-Stage3 |
5.810400E-02 |
| Normal-vs-Stage4 |
3.417600E-02 |
| Stage1-vs-Stage2 |
8.496200E-01 |
| Stage1-vs-Stage3 |
9.186600E-01 |
| Stage1-vs-Stage4 |
9.060800E-01 |
| Stage2-vs-Stage3 |
8.327200E-01 |
| Stage2-vs-Stage4 |
8.018200E-01 |
| Stage3-vs-Stage4 |
9.961200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.204000E-02 |
| Normal-vs-AfricanAmerican |
4.1671999999604E-06 |
| Normal-vs-Asian |
5.466400E-01 |
| Caucasian-vs-AfricanAmerican |
3.984500E-04 |
| Caucasian-vs-Asian |
1.204020E-01 |
| AfricanAmerican-vs-Asian |
1.030950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.419500E-02 |
| Normal-vs-Female |
1.880690E-03 |
| Male-vs-Female |
9.674500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.346200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.460700E-03 |
| Normal-vs-Age(61-80Yrs) |
7.453600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.598400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.820600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.310000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.981400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.450200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.779400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.700400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.267170E-01 |
| Normal-vs-Grade 2 |
3.400200E-02 |
| Normal-vs-Grade 3 |
1.462180E-02 |
| Normal-vs-Grade 4 |
1.025200E-01 |
| Grade 1-vs-Grade 2 |
7.271200E-01 |
| Grade 1-vs-Grade 3 |
8.232600E-01 |
| Grade 1-vs-Grade 4 |
7.519600E-01 |
| Grade 2-vs-Grade 3 |
6.319400E-01 |
| Grade 2-vs-Grade 4 |
9.721200E-01 |
| Grade 3-vs-Grade 4 |
7.734200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.250300E-02 |
| Normal-vs-ccB subtype |
3.937800E-01 |
| ccA subtype-vs-ccB subtype |
1.671370E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.940200E-02 |
| Normal-vs-N1 |
8.473800E-01 |
| N0-vs-N1 |
4.807800E-01 |
|
|
